Apyx Medical Corporation (APYX) Stock Analysis & Winston Score

Apyx Medical is a small medical device company that makes energy-based tools used by doctors during surgical procedures. Its main product is Helium Plasma technology, sold under the Renuvion brand, which uses a combination of helium gas and electrical energy to tighten skin and treat tissue. The company sells primarily to plastic surgeons, dermatologists, and cosmetic surgery centers in the United States. Apyx earns money by selling its Renuvion handpiece devices and the single-use disposable components that go with each procedure, creating some repeat revenue every time a doctor uses the system. The company operates mainly in the U.S. but has a small international presence. With a market cap around $200 million and negative operating margins, Apyx is not yet consistently profitable. Its key growth driver is expanding cleared uses for Renuvion — the FDA has approved it for several body contouring indications — but the main risk is that it must grow procedure volume fast enough to cover its operating costs.